Stocks Intraday Alert: Oclaro, Inc. (OCLR), SUPERVALU Inc. (SVU), Invesco Ltd. (IVZ)

Oclaro, Inc. (OCLR) continued its downward trend with the stock declining -0.61% or $-0.05 to close the day at $8.13 on lower than average trading volume of 3.53M shares, compared to its three month average trading volume of 5.36M. The San Jose California 95131 based company has been outperforming the semiconductor equipment & materials companies by 3.5793% for last three months and its recent gains have offset losses to -9.16% YTD, versus the semiconductor equipment & materials industry which is up 5.8% for the same period. The RSI of 38.68 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

Oclaro, Inc. designs, manufactures, and markets lasers and optical components, modules, and subsystems for the optical communications, industrial, and consumer laser markets worldwide. The company’s products generate, detect, combine, and separate light signals in optical communications networks. It offers client side transceivers, including pluggable transceivers; line side transceivers; tunable laser transmitters, such as discrete lasers and co-packaged laser modulators; lithium niobate modulators to manipulate the phase or the amplitude of an optical signal; transponder modules for transmitter and receiver functions; and discrete lasers and receivers for metro and long-haul applications. The company markets its products through direct sales force, as well as through sales representatives and resellers. It serves network equipment manufacturers of telecommunications and datacom systems, and hyperscale data center operators. The company was formerly known as Bookham, Inc. and changed its name to Oclaro, Inc. in April 2009. Oclaro, Inc. was founded in 1988 and is headquartered in San Jose, California.

SUPERVALU Inc. (SVU) had a light trading with around 3.53M shares changing hands compared to its three month average trading volume of 3.84M. The stock traded between $4.22 and $4.38 before closing at the price of $4.38 with 0.92% change on the day. The Eden Prairie Minnesota 55344 based company is currently trading 11.17% above its 52 week low of $3.94 and -29.01% below its 52 week high of $6.17. Both the RSI indicator and target price of 38.51 and $5.69 respectively, lead us to believe that it should be put on hold over the coming weeks.

SUPERVALU INC., together with its subsidiaries, operates as a grocery wholesaler and retailer in the United States. The company operates through three segments: Wholesale, Save-A-Lot, and Retail. The Wholesale segment offers wholesale distribution of various food and non-food products to independent retail customers, such as single and multiple grocery store independent operators, regional chains, and the military. This segment operates approximately 1,796 stores with a network spanning 40 states. The Save-A-Lot segment owns, operates, and licenses 1,360 discount grocery stores under the Save-A-Lot banner, including 897 licensed Save-A-Lot stores and 463 company-operated stores. The Retail segment operates retail stores that provide groceries and various additional products, including general merchandise, home, health and beauty care, and pharmacy products. This segment operates 200 stores under the Cub Foods, Shoppers Food & Pharmacy, Shop ’n Save, Farm Fresh, and Hornbacher’s banners, as well as 2 Rainbow and 2 County Market stores. The company provides a range of brand name and private-label products comprising perishable and nonperishable grocery products. SUPERVALU INC. was founded in 1871 and is headquartered in Eden Prairie, Minnesota.

Invesco Ltd. (IVZ) traded within a range of $30.24 to $30.57 after opening the day at $30.43. The company has seen its stock increase in value by 0.69% so far this year. The stock was down close to 0% on active volume in last trading session and closed at $30.55 per share. After the recent fall, the stock is currently holding -8.37% below its 52 week high of $33.34 and 35.22% above its 12-month low of $23.02. The shares are up by over 4.28% in the last three months, and the RSI indicator value of 42.23 is neither bullish nor bearish, tempting investors to stay on the sidelines.

Invesco Ltd. is a publicly owned investment manager. The firm provides its services to retail clients, institutional clients, high-net worth clients, public entities, corporations, unions, non-profit organizations, endowments, foundations, pension funds, financial institutions, and sovereign wealth funds. It manages separate client-focused equity and fixed income portfolios. The firm also launches equity, fixed income, commodity, multi-asset, and balanced mutual funds for its clients. It launches equity, fixed income, multi-asset, and balanced exchange-traded funds. The firm also launches and manages private funds. It invests in the public equity and fixed income markets across the globe. The firm also invests in alternative markets, such as commodities and currencies. For the equity portion of its portfolio, it invests in growth and value stocks of large-cap, mid-cap, and small-cap companies. For the fixed income portion of its portfolio, the firm invests in convertibles, government bonds, municipal bonds, treasury securities, and cash. It also invests in short term and intermediate term bonds, investment grade and high yield bonds, taxable and tax-free bonds, senior secured loans, and structured securities such as asset-backed securities, mortgage-backed securities, and commercial mortgage-backed securities. The firm employs absolute return, global macro, and long/short strategies. It employs quantitative analysis to make its investments. The firm was formerly known as Invesco Plc, AMVESCAP plc, Amvesco plc, Invesco PLC, Invesco MIM, and H. Lotery & Co. Ltd. Invesco Ltd. was founded in December 1935 and is based in Atlanta, Georgia with an additional office in Hamilton, Bermuda.

 

Stocks Buzz: MGIC Investment Corporation (MTG), Oclaro, Inc. (OCLR), Immune Pharmaceuticals, Inc. (IMNP)

MGIC Investment Corporation (MTG) continued its downward trend with the stock declining -1.29% or $-0.13 to close the day at $9.97 on active trading volume of 5.53M shares, compared to its three month average trading volume of 5.26M. The Milwaukee Wisconsin 53202 based company has been outperforming the property & casualty insurance group over the past 52 weeks, with the stock gaining 34.55%, compared to the industry which has advanced 25.66% over the same period. With RSI of 45.97, the stock should still continue to rise and get closer to its one year target estimate of $11.4, making it a hold for now.

MGIC Investment Corporation, through its subsidiaries, provides private mortgage insurance and ancillary services to lenders and government sponsored entities in the United States. The company offers primary mortgage insurance that provides mortgage default protection on individual loans, as well as covers unpaid loan principal, delinquent interest, and various expenses associated with the default and subsequent foreclosure. It also provides contract underwriting services; and other services for the mortgage finance industry, such as analysis of loan originations and portfolios, and mortgage lead generation services. In addition, the company participates in external reinsurance arrangements and captive mortgage reinsurance arrangements. It serves originators of residential mortgage loans, including savings institutions, commercial banks, mortgage brokers, credit unions, mortgage bankers, and other lenders. The company was founded in 1957 and is headquartered in Milwaukee, Wisconsin.

Oclaro, Inc. (OCLR) retreated with the stock falling -3.65% or $-0.31 to close at $8.18 on active trading volume of 5.49M compared its three months average trading volume of 5.3M. The San Jose California 95131 based company operating under the Semiconductor Equipment & Materials industry has been trending up for the last 52 weeks, with the shares price now 130.42% up for the period and down by -8.6% so far this year. With price target of $12.19 and a 154.04% rebound from 52-week low, Oclaro, Inc. has plenty of upside potential, making it a hold with a view buy.

Oclaro, Inc. designs, manufactures, and markets lasers and optical components, modules, and subsystems for the optical communications, industrial, and consumer laser markets worldwide. The company’s products generate, detect, combine, and separate light signals in optical communications networks. It offers client side transceivers, including pluggable transceivers; line side transceivers; tunable laser transmitters, such as discrete lasers and co-packaged laser modulators; lithium niobate modulators to manipulate the phase or the amplitude of an optical signal; transponder modules for transmitter and receiver functions; and discrete lasers and receivers for metro and long-haul applications. The company markets its products through direct sales force, as well as through sales representatives and resellers. It serves network equipment manufacturers of telecommunications and datacom systems, and hyperscale data center operators. The company was formerly known as Bookham, Inc. and changed its name to Oclaro, Inc. in April 2009. Oclaro, Inc. was founded in 1988 and is headquartered in San Jose, California.

Immune Pharmaceuticals, Inc. (IMNP) continued its upward trend with the stock climbing 1.96% or $0.01 to close the day at $0.22 on lower than average trading volume of 5.49M shares, compared to its three month average trading volume of 6.02M. The New York New York 10016 based company has been underperforming the drug manufacturers – major companies by -13.781% for last three months and its recent losses have trimmed gains to 19.89% YTD, versus the drug manufacturers – major industry which is up 0.53% for the same period. The RSI of 60.51 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

Immune Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops and commercializes novel targeted therapeutics in the immuno-inflammation and immuno-oncology areas. The company’s lead product candidate is Bertilimumab, a human monoclonal antibody, which is in Phase II clinical trial for the treatment of ulcerative colitis, bullous pemphigoid, and Crohn’s disease. It is also developing NanoCyclo, a topical nanocapsule formulation of cyclosporine, for the treatment of psoriasis and atopic dermatitis; Ceplene, a small molecule, which has completed Phase III clinical trials targeting the Histamine-2 Receptor to overcome immunosuppression in Acute Myeloid Leukemia and other malignancies; Azixa, a Phase II clinical trial novel microtubular destabilizer that functions as a vascular disruption agent; and Crolibulin, a novel small molecule vascular disruption agent and apoptosis inducer, which is in Phase II clinical trials for the treatment of patients with solid tumors. The company’s products also include NanomAbs technology platform, an antibody-drug conjugate platform for the treatment of cancer; novel technology platform for the construction of bispecific antibodies for immunotherapies; and AmiKet, a prescription topical analgesic cream, which is in Phase III clinical trial to treat peripheral neuropathies. It has license, and other collaborative research and development arrangements with BioNanoSim Ltd.; Yissum Research Development Company of The Hebrew University of Jerusalem Ltd.; Atlante Biotech SAS; Shire Biochem, Inc.; Lonza Sales AG; MabLife SAS; iCo Therapeutics Inc.; Dalhousie University; and Endo Pharmaceuticals Inc. Immune Pharmaceuticals, Inc. was founded in 2010 and is headquartered in New York, New York.

 

Trader’s Round Up: ConocoPhillips (COP), Oclaro, Inc. (OCLR), Visa Inc. (V)

ConocoPhillips (COP) retreated with the stock falling -2.09% or $-1.07 to close at $50.15 on light trading volume of 6.95M compared its three months average trading volume of 7.63M. The Houston Texas 77079 based company operating under the Independent Oil & Gas industry has been trending up for the last 52 weeks, with the shares price now 31.87% up for the period and up by 0.02% so far this year. With price target of $55.68 and a 64.36% rebound from 52-week low, ConocoPhillips has plenty of upside potential, making it a hold with a view buy.

ConocoPhillips explores for, produces, transports, and markets crude oil, bitumen, natural gas, liquefied natural gas, and natural gas liquids worldwide. Its portfolio includes resource-rich North American tight oil and oil sands assets; lower-risk legacy assets in North America, Europe, Asia, and Australia; various international developments; and an inventory of conventional and unconventional exploration prospects. The company was founded in 1917 and is headquartered in Houston, Texas.

Oclaro, Inc. (OCLR) gained $0.15 to close the day at a new closing price of $8.57, a 1.78% increase in value from its previous closing price that moved the stock 166.15% above its 52 week low of $3.16. A total of 6.93M shares exchanged hands during the day compared with its three month average trading volume of 5.23M. The stock, which fluctuated between $8.32 and $8.78 during the day, currently situated -15.9% below its 52 week high. The stock is up by 3% in the past one month and up by 2.51% over the past three months. With a one year target estimate of $12.19 and RSI of 47.96, the stock still has upside potential, making it a hold for now.

Oclaro, Inc. designs, manufactures, and markets lasers and optical components, modules, and subsystems for the optical communications, industrial, and consumer laser markets worldwide. The company’s products generate, detect, combine, and separate light signals in optical communications networks. It offers client side transceivers, including pluggable transceivers; line side transceivers; tunable laser transmitters, such as discrete lasers and co-packaged laser modulators; lithium niobate modulators to manipulate the phase or the amplitude of an optical signal; transponder modules for transmitter and receiver functions; and discrete lasers and receivers for metro and long-haul applications. The company markets its products through direct sales force, as well as through sales representatives and resellers. It serves network equipment manufacturers of telecommunications and datacom systems, and hyperscale data center operators. The company was formerly known as Bookham, Inc. and changed its name to Oclaro, Inc. in April 2009. Oclaro, Inc. was founded in 1988 and is headquartered in San Jose, California.

Visa Inc. (V) shares were down in last trading by -0.53% to $81.37. It experienced lighter than average volume on day. The stock increased in value by almost 0.35% over the past week and grew 3.66% in the past month. It is currently trading 2.19% above its 50 day moving average and 2.51% above its 200 day moving average. Following the recent decrease in price, the stock’s new closing price represents a -2.88% decrease in value from its one year high of $83.96. The RSI indicator value of 58.21, lead us to believe that it is a hold for now.

Visa Inc. operates as a payments technology company worldwide. The company facilitates commerce through the transfer of value and information among consumers, merchants, financial institutions, businesses, strategic partners, and government entities. It operates VisaNet, a processing network that enables authorization, clearing, and settlement of payment transactions; and offers fraud protection for account holders and assured payment for merchants. The company also offers gateway services for merchants to accept, process, and reconcile payments; manage fraud; and safeguard payment security online, as well as processing services for participating issuers of visa debit, prepaid, and ATM payment products. In addition, it provides digital products, including Visa Checkout that offers consumers an expedited and secure payment experience for online transactions; and Visa Direct, a push payment product platform, which facilitates payer-initiated transactions that are sent directly to the Visa account of the recipient, as well as Visa token service that replaces the card account numbers from the transaction with a token. Further the company offers corporate (travel) and purchasing card products, as well as value-added services. It provides its services under the Visa, Visa Electron, Interlink, V PAY, and PLUS brands. The company has a strategic partnership agreement with Oman Arab Bank to convert the bank’s current electron cards to chip-and-PIN debit cards. Visa Inc. was incorporated in 2007 and is headquartered in San Francisco, California.

 

Stocks on the Move: Devon Energy Corporation (DVN), QEP Resources, Inc. (QEP), Oclaro, Inc. (OCLR)

Devon Energy Corporation (DVN) continued its upward trend with the stock climbing 1.5% or $0.7 to close the day at $47.4 on light trading volume of 4M shares, compared to its three month average trading volume of 5.18M. The Oklahoma City Oklahoma 73102 based company has been outperforming the independent oil & gas group over the past 52 weeks, with the stock gaining 87.09%, compared to the industry which has advanced 54.14% over the same period. With RSI of 53.97, the stock should still continue to rise and get closer to its one year target estimate of $51.3, making it a hold for now.

Devon Energy Corporation, an independent energy company, primarily engages in the exploration, development, and production of oil, natural gas, and natural gas liquids (NGLs) in the United States and Canada. It operates approximately 19,000 wells. The company also offers midstream energy services, including gathering, transmission, processing, fractionation, and marketing to producers of natural gas, NGLs, crude oil, and condensate through its natural gas pipelines, plants, and treatment facilities. Devon Energy Corporation was founded in 1971 and is headquartered in Oklahoma City, Oklahoma.

QEP Resources, Inc. (QEP) climbed 1.34% during last trading as the stock added $0.24 to finish the day at $18.1 with about 3.98M shares changing hands, compared to its three month average trading volume of 3.61M. The $4.35B market cap company, which fluctuated between $17.57 and $18.12 during the day, currently situated 111.94% above its 52 week low of $8.54 and -14.3% away from its one year high of $21.12. The RSI of 43.9 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

QEP Resources, Inc., through its subsidiaries, operates as a natural gas and crude oil exploration and production company in the United States. The company conducts exploration and production activities in the Pinedale Anticline in western Wyoming; the Williston Basin in North Dakota; the Uinta Basin in eastern Utah; the Permian Basin in western Texas; the Haynesville/Cotton Valley in northwestern Louisiana; and other proven properties in Wyoming, Utah, and Colorado. As of December 31, 2015, it had estimated proved reserves of 3,620.2 billion cubic feet of natural gas equivalents. The company sells its gas, oil, and natural gas liquids (NGL) to various customers, including gas-marketing firms, industrial users, local-distribution companies, crude oil refiners, and remarketers, as well as markets affiliate and third-party gas, oil, and NGL volumes. In addition, it operates a gas gathering system and an underground gas storage facility. QEP Resources, Inc. is headquartered in Denver, Colorado.

Oclaro, Inc. (OCLR) saw its value decrease by -1.41% as the stock dropped $-0.12 to finish the day at a closing price of $8.42. The stock was lighter in trading and has fluctuated between $3.16-$10.19 per share for the past year. The shares are up by 0.36% in the past three months and up by 65.75% over the past six months. It is currently trading -4.88% below its 20 day moving average and -3.43% below its 50 day moving average. Analysts believe the company can continue to increase in value to reach at $12.19 a share over the next twelve months. The current relative strength index (RSI) reading is 46.05. The technical indicator lead us to believe there will be no major movement any time soon, hold.

Oclaro, Inc. designs, manufactures, and markets lasers and optical components, modules, and subsystems for the optical communications, industrial, and consumer laser markets worldwide. The company’s products generate, detect, combine, and separate light signals in optical communications networks. It offers client side transceivers, including pluggable transceivers; line side transceivers; tunable laser transmitters, such as discrete lasers and co-packaged laser modulators; lithium niobate modulators to manipulate the phase or the amplitude of an optical signal; transponder modules for transmitter and receiver functions; and discrete lasers and receivers for metro and long-haul applications. The company markets its products through direct sales force, as well as through sales representatives and resellers. It serves network equipment manufacturers of telecommunications and datacom systems, and hyperscale data center operators. The company was formerly known as Bookham, Inc. and changed its name to Oclaro, Inc. in April 2009. Oclaro, Inc. was founded in 1988 and is headquartered in San Jose, California.

 

Stocks Highlights: Oclaro, Inc. (OCLR), Helix Energy Solutions Group, Inc. (HLX), American Eagle Outfitters, Inc. (AEO)

Oclaro, Inc. (OCLR) had a active trading with around 7.34M shares changing hands compared to its three month average trading volume of 5.17M. The stock traded at the price of $8.54 with 3.26% change on the day. The San Jose California 95131 based company is currently trading 170.25% above its 52 week low of $3.16 and -16.19% below its 52 week high of $10.19. Both the RSI indicator and target price of 46.94 and $12.19 respectively, lead us to believe that it should be put on hold over the coming weeks.

Oclaro, Inc. designs, manufactures, and markets lasers and optical components, modules, and subsystems for the optical communications, industrial, and consumer laser markets worldwide. The company’s products generate, detect, combine, and separate light signals in optical communications networks. It offers client side transceivers, including pluggable transceivers; line side transceivers; tunable laser transmitters, such as discrete lasers and co-packaged laser modulators; lithium niobate modulators to manipulate the phase or the amplitude of an optical signal; transponder modules for transmitter and receiver functions; and discrete lasers and receivers for metro and long-haul applications. The company markets its products through direct sales force, as well as through sales representatives and resellers. It serves network equipment manufacturers of telecommunications and datacom systems, and hyperscale data center operators. The company was formerly known as Bookham, Inc. and changed its name to Oclaro, Inc. in April 2009. Oclaro, Inc. was founded in 1988 and is headquartered in San Jose, California.

Helix Energy Solutions Group, Inc. (HLX) continued its downward trend with the stock declining -6.64% or $-0.62 to close the day at $8.72 on active trading volume of 7.31M shares, compared to its three month average trading volume of 2.44M. The Houston Texas 77043 based company has been outperforming the oil & gas equipment & services group over the past 52 weeks, with the stock gaining 86.32%, compared to the industry which has advanced 38.95% over the same period. With RSI of 39.87, the stock should still continue to rise and get closer to its one year target estimate of $12.18, making it a hold for now.

Helix Energy Solutions Group, Inc., together with its subsidiaries, provides specialty services to the offshore energy industry primarily in the Gulf of Mexico, North Sea, the Asia Pacific, and West Africa regions. It operates through three segments: Well Intervention, Robotics, and Production Facilities. The company engineers, manages, and conducts well construction, intervention, and abandonment operations in water depths ranging from 200 to 10,000 feet; and operates remotely operated vehicles (ROVs), trenchers, and ROVDrills for offshore construction, maintenance, and well intervention services. It also offers well intervention; intervention engineering; production enhancement; inspection, repair, and maintenance of production structures, trees, jumpers, risers, pipelines, and subsea equipment; and life of field support. In addition, the company provides reclamation and remediation services; well plugging and abandonment services; pipeline abandonment services; and site inspections. Further, it engages in the installation of subsea pipelines, flowlines, control umbilicals, manifold assemblies, and risers; burial of pipelines; installation and tie-in of riser and manifold assembly; commissioning, testing, and inspection activities; and provision of cable and umbilical lay, and connection services. Additionally, the company offers oil and natural gas processing services to oil and natural gas companies; and fast response system services. It serves independent oil and gas producers and suppliers, pipeline transmission companies, alternative energy companies, and offshore engineering and construction firms. The company was formerly known as Cal Dive International, Inc. and changed its name to Helix Energy Solutions Group, Inc. in March 2006. Helix Energy Solutions Group, Inc. was incorporated in 1979 and is headquartered in Houston, Texas.

American Eagle Outfitters, Inc. (AEO) shares were up in last trading by 1.8% to $15.24. It experienced higher than average volume on day. The stock decreased in value by almost -1.42% over the past week and fell -15.33% in the past month. It is currently trading -9.02% below its 50 day moving average and -7.57% below its 200 day moving average. Following the recent increase in price, the stock’s new closing price represents a -20.89% decrease in value from its one year high of $19.55. The RSI indicator value of 43.46, lead us to believe that it is a hold for now.

American Eagle Outfitters, Inc. operates as a specialty retailer offering on-trend clothing, accessories, and personal care products under the American Eagle Outfitters and Aerie brands. The company provides denim, bottoms, and other apparel, as well as footwear and accessories for men and women; and intimates, including bras, undies, swim, and other products, as well as apparel and personal care products for women. In addition, it offers sports apparel under the Tailgate brand; and menswear products under the Todd Snyder New York brand name. The company operates approximately 1,000 stores in the United States, Canada, Mexico, China, Hong Kong, and the United Kingdom, and ships to 81 countries through its websites. It also offers its merchandise at 151 stores operated by licensees in 22 countries, as well as through its Websites at ae.com, aerie.com, TailgateClothing.com, and ToddSnyder.com. American Eagle Outfitters, Inc. was founded in 1977 and is headquartered in Pittsburgh, Pennsylvania.

 

Stocks In Action: Colony Capital, Inc. (CLNY), Oclaro, Inc. (OCLR), Philip Morris International Inc. (PM)

Colony Capital, Inc. (CLNY) traded within a range of $21.25 to $21.91 after opening the day at $21.66. The company has seen its stock increase in value by 4.99% so far this year. The stock was down close to -1.53% on active volume in last trading session and closed at $21.26 per share. After the recent fall, the stock is currently holding -3.01% below its 52 week high of $21.92 and 55.45% above its 12-month low of $14.73. The shares are up by over 21.72% in the last three months, and the RSI indicator value of 59.9 is neither bullish nor bearish, tempting investors to stay on the sidelines.

Colony Capital, Inc. is a real estate investment trust. The firm invests in the real estate markets of North America and Europe. Its investment portfolio is primarily composed of real estate equity; real estate and real estate-related debt; and investment management of company-sponsored private equity funds and vehicles. The firm invests in wide spectrum of commercial real estate property types, including but not limited to, office, industrial, retail, hospitality, education, single-family and multifamily residential assets, and geographies, primarily within North America and Europe. It was formerly known as Colony Financial, Inc. Colony Capital, Inc. was formed on June 23, 2009 and is based in Los Angeles, California.

Oclaro, Inc. (OCLR) continued its downward trend with the stock declining -0.84% or $-0.07 to close the day at $8.27 on light trading volume of 3.52M shares, compared to its three month average trading volume of 5.16M. The San Jose California 95131 based company has been outperforming the semiconductor equipment & materials group over the past 52 weeks, with the stock gaining 150.61%, compared to the industry which has advanced 43.44% over the same period. With RSI of 41.21, the stock should still continue to rise and get closer to its one year target estimate of $12.19, making it a hold for now.

Oclaro, Inc. designs, manufactures, and markets lasers and optical components, modules, and subsystems for the optical communications, industrial, and consumer laser markets worldwide. The company’s products generate, detect, combine, and separate light signals in optical communications networks. It offers client side transceivers, including pluggable transceivers; line side transceivers; tunable laser transmitters, such as discrete lasers and co-packaged laser modulators; lithium niobate modulators to manipulate the phase or the amplitude of an optical signal; transponder modules for transmitter and receiver functions; and discrete lasers and receivers for metro and long-haul applications. The company markets its products through direct sales force, as well as through sales representatives and resellers. It serves network equipment manufacturers of telecommunications and datacom systems, and hyperscale data center operators. The company was formerly known as Bookham, Inc. and changed its name to Oclaro, Inc. in April 2009. Oclaro, Inc. was founded in 1988 and is headquartered in San Jose, California.

Philip Morris International Inc. (PM) dropped $-0.53 to close the day at a new closing price of $91.31, a -0.58% decrease in value from its previous closing price that moved the stock 12.77% above its 52 week low of $84.46. A total of 3.52M shares exchanged hands during the day compared with its three month average trading volume of 5.02M. The stock, which fluctuated between $90.83 and $91.44 during the day, currently situated -10.45% below its 52 week high. The stock is up by 2.77% in the past one month and down by -3.81% over the past three months. With a one year target estimate of $100.69 and RSI of 49.48, the stock still has upside potential, making it a hold for now.

Philip Morris International Inc., through its subsidiaries, manufactures and sells cigarettes, other tobacco products, and other nicotine-containing products. Its portfolio of brands comprises Marlboro, Merit, Parliament, Virginia S., L&M, Philip Morris, Bond Street, Chesterfield, Lark, Muratti, Next, and Red & White. The company also owns various cigarette brands, such as Dji Sam Soe, Sampoerna, and U Mild in Indonesia; Champion, Fortune, and Hope in the Philippines; Apollo-Soyuz and Optima in Russia; Morven Gold in Pakistan; Boston in Colombia; Belmont, Canadian Classics, and Number 7 in Canada; Best in Serbia; f6 in Germany; Delicados in Mexico; Assos in Greece; and Petra in the Czech Republic and Slovakia. It markets and sells its products in approximately 180 countries in the European Union, Eastern Europe, the Middle East, Africa, Asia, Latin America, and Canada. Philip Morris International Inc. was incorporated in 1987 and is based in New York, New York.

 

Stocks Trend Analysis: Delcath Systems, Inc. (DCTH) Oclaro, Inc. (OCLR) Altria Group, Inc. (MO)

Delcath Systems, Inc. (DCTH) continued its downward trend with the stock declining -29.34% or $-0.24 to close the day at $0.58 on active trading volume of 4.95M shares, compared to its three month average trading volume of 277.22K. The New York New York 10019 based company has been underperforming the drug delivery group over the past 52 weeks, with the stock losing -99.53%, compared to the industry which has dropped -66.42% over the same period. With RSI of 19.09, the stock should still continue to rise and get closer to its one year target estimate of $16, making it a hold for now.

Delcath Systems, Inc. operates as a specialty pharmaceutical and medical device company focusing on cancers of the liver. The company is developing its proprietary product-Melphalan Hydrochloride for injection for use with the Delcath Hepatic Delivery System; and markets melphalan hydrochloride as a device under the trade name Delcath Hepatic CHEMOSAT Delivery System for Melphalan in Europe. Its primary focus is on the execution of its clinical development program in ocular melanoma liver metastases, intrahepatic cholangiocarcinoma, hepatocellular carcinoma, and certain other cancers that are metastatic to the liver. Delcath Systems, Inc. was founded in 1988 and is headquartered in New York, New York.

Oclaro, Inc. (OCLR) retreated with the stock falling -2.8% or $-0.24 to close at $8.34 on light trading volume of 4.93M compared its three months average trading volume of 5.13M. The San Jose California 95131 based company operating under the Semiconductor Equipment & Materials industry has been trending up for the last 52 weeks, with the shares price now 142.44% up for the period and down by -6.82% so far this year. With price target of $12.19 and a 163.92% rebound from 52-week low, Oclaro, Inc. has plenty of upside potential, making it a hold with a view buy.

Oclaro, Inc. designs, manufactures, and markets lasers and optical components, modules, and subsystems for the optical communications, industrial, and consumer laser markets worldwide. The company’s products generate, detect, combine, and separate light signals in optical communications networks. It offers client side transceivers, including pluggable transceivers; line side transceivers; tunable laser transmitters, such as discrete lasers and co-packaged laser modulators; lithium niobate modulators to manipulate the phase or the amplitude of an optical signal; transponder modules for transmitter and receiver functions; and discrete lasers and receivers for metro and long-haul applications. The company markets its products through direct sales force, as well as through sales representatives and resellers. It serves network equipment manufacturers of telecommunications and datacom systems, and hyperscale data center operators. The company was formerly known as Bookham, Inc. and changed its name to Oclaro, Inc. in April 2009. Oclaro, Inc. was founded in 1988 and is headquartered in San Jose, California.

Altria Group, Inc. (MO) continued its upward trend with the stock climbing 0.44% or $0.3 to close the day at $68.23 on lower than average trading volume of 4.91M shares, compared to its three month average trading volume of 6.74M. The Richmond Virginia 23230 based company has been underperforming the cigarettes companies by 10.44% for last three months and its recent gains have pushed the stock slightly up 0.9% YTD, versus the cigarettes industry which is down -4.83% for the same period. The RSI of 63.53 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

Altria Group, Inc., through its subsidiaries, manufactures and sells cigarettes, smokeless products, and wine in the United States. It offers cigarettes primarily under the Marlboro brand; cigars principally under the Black & Mild brand; and moist smokeless tobacco products under the Copenhagen and Skoal, Red Seal and Husky, and Marlboro Snus brand names. The company also produces and sells varietal and blended table wines, and sparkling wines under the Chateau Ste. Michelle, Columbia Crest, and 14 Hands names; and imports and markets Antinori, Torres, and Villa Maria Estate wines, as well as Champagne Nicolas Feuillatte in the United States. In addition, it provides finance leasing services primarily in aircraft, railcar, electric power, real estate, and manufacturing industries. The company sells its tobacco products primarily to wholesalers, including distributors; large retail organizations, such as chain stores; and the armed services. Altria Group, Inc. was founded in 1919 and is headquartered in Richmond, Virginia.

 

3 Trending Stocks: Oclaro, Inc. (OCLR), Orexigen Therapeutics, Inc. (OREX), AbbVie Inc. (ABBV)

Oclaro, Inc. (OCLR) continued its upward trend with the stock climbing 1.66% or $0.14 to close the day at $8.58 on active trading volume of 5.41M shares, compared to its three month average trading volume of 5.12M. The San Jose California 95131 based company has been outperforming the semiconductor equipment & materials group over the past 52 weeks, with the stock gaining 141.69%, compared to the industry which has advanced 34.89% over the same period. With RSI of 46.88, the stock should still continue to rise and get closer to its one year target estimate of $12.19, making it a hold for now.

Oclaro, Inc. designs, manufactures, and markets lasers and optical components, modules, and subsystems for the optical communications, industrial, and consumer laser markets worldwide. The company’s products generate, detect, combine, and separate light signals in optical communications networks. It offers client side transceivers, including pluggable transceivers; line side transceivers; tunable laser transmitters, such as discrete lasers and co-packaged laser modulators; lithium niobate modulators to manipulate the phase or the amplitude of an optical signal; transponder modules for transmitter and receiver functions; and discrete lasers and receivers for metro and long-haul applications. The company markets its products through direct sales force, as well as through sales representatives and resellers. It serves network equipment manufacturers of telecommunications and datacom systems, and hyperscale data center operators. The company was formerly known as Bookham, Inc. and changed its name to Oclaro, Inc. in April 2009. Oclaro, Inc. was founded in 1988 and is headquartered in San Jose, California.

Orexigen Therapeutics, Inc. (OREX) climbed 11.18% during last trading as the stock added $0.38 to finish the day at $3.78 with about 5.39M shares changing hands, compared to its three month average trading volume of 340.54K. The $55.14M market cap company, which fluctuated between $2.93 and $3.98 during the day, currently situated 129.09% above its 52 week low of $1.65 and -80.91% away from its one year high of $19.8. The RSI of 82.75 indicates the stock is overbought at the current levels, sell for now.

Orexigen Therapeutics, Inc., a biopharmaceutical company, focuses on the development of pharmaceutical products. The company offers Contrave for the treatment of obesity. It has a collaboration agreement with Takeda Pharmaceutical Company Limited to develop and commercialize Contrave in the United States, Canada, and Mexico. The company’s product, Contrave also approved under the brand name of Mysimba in Europe. Orexigen Therapeutics, Inc. was founded in 2002 and is headquartered in La Jolla, California.

AbbVie Inc. (ABBV) saw its value increase by 0.76% as the stock gained $0.48 to finish the day at a closing price of $63.77. The stock was lighter in trading and has fluctuated between $50.71-$68.12 per share for the past year. The shares, which traded within a range of $63.03 to $63.95 during the day, are up by 1.53% in the past three months and up by 2.35% over the past six months. It is currently trading 2.88% above its 20 day moving average and 4.82% above its 50 day moving average. Analysts believe the company can continue to increase in value to reach at $70 a share over the next twelve months. The current relative strength index (RSI) reading is 66.37. The technical indicator lead us to believe there will be no major movement any time soon, hold.

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products worldwide. The company offers HUMIRA, a biologic therapy administered as a subcutaneous injection to treat autoimmune diseases; IMBRUVICA, an oral therapy for the treatment of chronic lymphocytic leukemia; and VIEKIRA PAK, an interferon-free therapy, with or without ribavirin, for adults with genotype 1 chronic hepatitis, including those with compensated cirrhosis. It also provides Kaletra, an anti-HIV-1 medicine used with other anti-HIV-1 medications as a treatment that maintains viral suppression in HIV-1 patients; Norvir, a protease inhibitor indicated in combination with other antiretroviral agents to treat HIV-1; and Synagis to prevent respiratory syncytial virus infection in high risk infants. In addition, the company offers AndroGel, a testosterone replacement therapy for males diagnosed with symptomatic low testosterone; Creon, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid to treat hypothyroidism; and Lupron, a product for the palliative treatment of prostate cancer, and endometriosis and central precocious puberty, as well as for the treatment of patients with anemia. Further, it provides Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson’s disease; Sevoflurane, an anesthesia product for human use; TriCor, Trilipix, and Niaspan to treat metabolic conditions characterized by high cholesterol and/or high triglycerides; and Zemplar to treat secondary hyperparathyroidism. The company sells its products to wholesalers, distributors, government agencies, health care facilities, specialty pharmacies, and independent retailers from its distribution centers and public warehouses. AbbVie Inc. has strategic collaboration with C2N Diagnostics; Calico Life Sciences LLC; Infinity Pharmaceuticals, Inc.; Ablynx NV; Galapagos NV; and Alvine Pharmaceuticals, Inc. The company was incorporated in 2012 and is based in North Chicago, Illinois.

 

Stocks in Focus: Oclaro, Inc. (OCLR), Synergy Pharmaceuticals Inc. (SGYP), Macy’s, Inc. (M)

Oclaro, Inc. (OCLR) had a active trading with around 9.04M shares changing hands compared to its three month average trading volume of 5.03M. The stock traded between $8.17 and $8.65 before closing at the price of $8.44 with 0.24% change on the day. The San Jose California 95131 based company is currently trading 167.09% above its 52 week low of $3.16 and -17.17% below its 52 week high of $10.19. Both the RSI indicator and target price of 44.1 and $12.19 respectively, lead us to believe that it should be put on hold over the coming weeks.

Oclaro, Inc. designs, manufactures, and markets lasers and optical components, modules, and subsystems for the optical communications, industrial, and consumer laser markets worldwide. The company’s products generate, detect, combine, and separate light signals in optical communications networks. It offers client side transceivers, including pluggable transceivers; line side transceivers; tunable laser transmitters, such as discrete lasers and co-packaged laser modulators; lithium niobate modulators to manipulate the phase or the amplitude of an optical signal; transponder modules for transmitter and receiver functions; and discrete lasers and receivers for metro and long-haul applications. The company markets its products through direct sales force, as well as through sales representatives and resellers. It serves network equipment manufacturers of telecommunications and datacom systems, and hyperscale data center operators. The company was formerly known as Bookham, Inc. and changed its name to Oclaro, Inc. in April 2009. Oclaro, Inc. was founded in 1988 and is headquartered in San Jose, California.

Synergy Pharmaceuticals Inc. (SGYP) continued its upward trend with the stock climbing 6.88% or $0.43 to close the day at $6.68 on active trading volume of 9.02M shares, compared to its three month average trading volume of 3.85M. The New York New York 10170 based company has been outperforming the drug manufacturers – other group over the past 52 weeks, with the stock gaining 28.96%, compared to the industry which has dropped -34.94% over the same period. With RSI of 73.46, the stock should still continue to rise and get closer to its one year target estimate of $10.8, making it a hold for now.

Synergy Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development of drugs to treat gastrointestinal (GI) disorders and diseases. Its lead product candidate is plecanatide, a guanylyl cyclase C receptor agonist that is in Phase III clinical trials to treat chronic idiopathic constipation GI disorders; and for the treatment of constipation-predominant irritable bowel syndrome GI disorders. The company is also developing SP-333, which is in Phase II clinical trials to treat opioid induced constipation, as well as in Phase Ib clinical trials to treat ulcerative colitis. The company has a research collaboration with BIND Therapeutics, Inc. to develop ACCURINS for treatment of a range of cells with novel therapeutic payloads. Synergy Pharmaceuticals Inc. is headquartered in New York, New York.

Macy’s, Inc. (M) shares were up in last trading by 1.73% to $35.84. It experienced higher than average volume on day. The stock decreased in value by almost -1.89% over the past week and fell -14.84% in the past month. It is currently trading -8.56% below its 50 day moving average and -1.97% below its 200 day moving average. Following the recent increase in price, the stock’s new closing price represents a -20.33% decrease in value from its one year high of $45.5. The RSI indicator value of 36.67, lead us to believe that it is a hold for now.

Macy’s, Inc., together with its subsidiaries, operates stores, Websites, and mobile applications in the United States. Its stores and Websites sell a range of merchandise, including apparel and accessories for men, women, and children; cosmetics; home furnishings; and other consumer goods. The company also operates stores that offer a range of women’s, men’s, and children’s apparel; shoes; fashion accessories; housewares; home textiles; intimate apparel; and jewelry. As of November 14, 2016, it operated approximately 870 stores under the Macy’s, Bloomingdales, Bluemercury, Bloomingdale’s Outlet, and Macy’s Backstage brands, as well as Websites, including macys.com, bloomingdales.com, and bluemercury.com. In addition, it operates as a beauty products and spa retailer. The company was formerly known as Federated Department Stores, Inc. and changed its name to Macy’s, Inc. in June 2007. Macy’s, Inc. was founded in 1830 and is based in Cincinnati, Ohio.

 

Stocks in the Spotlight: McDonald’s Corporation (MCD), Under Armour, Inc. (UA), Oclaro, Inc. (OCLR)

McDonald’s Corporation (MCD) had a light trading with around 3.57M shares changing hands compared to its three month average trading volume of 4.26M. The stock traded between $121.44 and $123.16 before closing at the price of $121.72 with -0.87% change on the day. The Oak Brook Illinois 60523 based company is currently trading 11.32% above its 52 week low of $110.33 and -5.63% below its 52 week high of $131.96. Both the RSI indicator and target price of 57.36 and $127.96 respectively, lead us to believe that it should be put on hold over the coming weeks.

McDonald’s Corporation operates and franchises McDonald’s restaurants in the United States, Europe, the Asia/Pacific, the Middle East, Africa, Canada, and Latin America. The company’s restaurants offer various food products, soft drinks, coffee, and other beverages. As of December 31, 2015, it operated 36,525 restaurants, including 30,081 franchised restaurants comprising 21,147 franchised to conventional franchisees, 5,529 licensed to developmental licensees, and 3,405 licensed to foreign affiliates; and 6,444 company-operated restaurants. The company was founded in 1940 and is based in Oak Brook, Illinois.

Under Armour, Inc. (UA) managed to rebound with the stock climbing 0.2% or $0.05 to close the day at $25.17 on light trading volume of 3.57M shares, compared to its three month average trading volume of 5.79M. The Baltimore Maryland 21230 based company has been underperforming the textile – apparel clothing group over the past 52 weeks, with the stock losing -37.55%, compared to the industry which has dropped -10.37% over the same period. With RSI of 31.3, the stock should still continue to rise and get closer to its one year target estimate of $44, making it a hold for now.

Under Armour, Inc. together with its subsidiaries, develops, markets, and distributes branded performance apparel, footwear, and accessories for men, women, and youth primarily in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. The company offers its apparel in compression, fitted, and loose types to be worn in hot, cold, and in between the extremes. It provides various footwear products, including football, baseball, lacrosse, softball and soccer cleats, slides, performance training, running, basketball, and outdoor footwear. The company also offers accessories, which include headwear, bags, and gloves; and digital fitness platform licenses and subscriptions, as well as digital advertising, as well as licenses its brands. It primarily provides its products under the UA Logo, UNDER ARMOUR, UA, ARMOUR, HEATGEAR, COLDGEAR, ALLSEASONGEAR, PROTECT THIS HOUSE, and I WILL, as well as ARMOURBITE, ARMOURSTORM, ARMOUR FLEECE, and ARMOUR BRA trademarks. The company sells its products through wholesale channels, including national and regional sporting goods chains, independent and specialty retailers, department store chains, institutional athletic departments, and leagues and teams, as well as independent distributors; and directly to consumers through a network of brand and factory house stores, and Website. Under Armour, Inc. was founded in 1996 and is headquartered in Baltimore, Maryland.

Oclaro, Inc. (OCLR) shares were down in last trading by -2.08% to $8.95. It experienced lighter than average volume on day. The stock decreased in value by almost -6.28% over the past week and grew 0.11% in the past month. It is currently trading 3.33% above its 50 day moving average and 32.71% above its 200 day moving average. Following the recent decrease in price, the stock’s new closing price represents a -12.17% decrease in value from its one year high of $10.19. The RSI indicator value of 51.96, lead us to believe that it is a hold for now.

Oclaro, Inc. designs, manufactures, and markets lasers and optical components, modules, and subsystems for the optical communications, industrial, and consumer laser markets worldwide. The company’s products generate, detect, combine, and separate light signals in optical communications networks. It offers client side transceivers, including pluggable transceivers; line side transceivers; tunable laser transmitters, such as discrete lasers and co-packaged laser modulators; lithium niobate modulators to manipulate the phase or the amplitude of an optical signal; transponder modules for transmitter and receiver functions; and discrete lasers and receivers for metro and long-haul applications. The company markets its products through direct sales force, as well as through sales representatives and resellers. It serves network equipment manufacturers of telecommunications and datacom systems, and hyperscale data center operators. The company was formerly known as Bookham, Inc. and changed its name to Oclaro, Inc. in April 2009. Oclaro, Inc. was founded in 1988 and is headquartered in San Jose, California.